Selected research
Market Outlook & Growth Opportunities
Global Kits and Iodine-131 (I-131) Capsules Market Outlook and Growth Opportunities 2026
Market perspective
The global Kits and Iodine-131 (I-131) Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Kits and Iodine-131 (I-131) Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Kits and Iodine-131 (I-131) Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Kits and Iodine-131 (I-131) Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Kits and Iodine-131 (I-131) Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Kits and Iodine-131 (I-131) Capsules market include NTP Radioisotopes SOC, Jubilant DraxImage and IRE - IRE ELiT, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Kits and Iodine-131 (I-131) Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Kits and Iodine-131 (I-131) Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Kits and Iodine-131 (I-131) Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Kits and Iodine-131 (I-131) Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Kits and Iodine-131 (I-131) Capsules Segment by Company
NTP Radioisotopes SOC
Jubilant DraxImage
IRE - IRE ELiT
Kits and Iodine-131 (I-131) Capsules Segment by Type
Kits
Capsules
Kits and Iodine-131 (I-131) Capsules Segment by Application
Medical
Industrial
Kits and Iodine-131 (I-131) Capsules Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Kits and Iodine-131 (I-131) Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Kits and Iodine-131 (I-131) Capsules market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Kits and Iodine-131 (I-131) Capsules significant trends, drivers, influence factors in global and regions.
6. To analyze Kits and Iodine-131 (I-131) Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kits and Iodine-131 (I-131) Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kits and Iodine-131 (I-131) Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kits and Iodine-131 (I-131) Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Kits and Iodine-131 (I-131) Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Kits and Iodine-131 (I-131) Capsules industry.
Chapter 3: Detailed analysis of Kits and Iodine-131 (I-131) Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Kits and Iodine-131 (I-131) Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Kits and Iodine-131 (I-131) Capsules in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Kits
- Capsules
Applications
- Medical
- Industrial
Companies covered
- NTP Radioisotopes SOC
- Jubilant DraxImage
- IRE - IRE ELiT
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Kits and Iodine-131 (I-131) Capsules Sales Value (2021-2032)
- 1.2.2 Global Kits and Iodine-131 (I-131) Capsules Sales Volume (2021-2032)
- 1.2.3 Global Kits and Iodine-131 (I-131) Capsules Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Kits and Iodine-131 (I-131) Capsules Market Dynamics
- 2.1 Kits and Iodine-131 (I-131) Capsules Industry Trends
- 2.2 Kits and Iodine-131 (I-131) Capsules Industry Drivers
- 2.3 Kits and Iodine-131 (I-131) Capsules Industry Opportunities and Challenges
- 2.4 Kits and Iodine-131 (I-131) Capsules Industry Restraints
3 Kits and Iodine-131 (I-131) Capsules Market by Company
- 3.1 Global Kits and Iodine-131 (I-131) Capsules Company Revenue Ranking in 2025
- 3.2 Global Kits and Iodine-131 (I-131) Capsules Revenue by Company (2021-2026)
- 3.3 Global Kits and Iodine-131 (I-131) Capsules Sales Volume by Company (2021-2026)
- 3.4 Global Kits and Iodine-131 (I-131) Capsules Average Price by Company (2021-2026)
- 3.5 Global Kits and Iodine-131 (I-131) Capsules Company Ranking (2024-2026)
- 3.6 Global Kits and Iodine-131 (I-131) Capsules Company Manufacturing Base and Headquarters
- 3.7 Global Kits and Iodine-131 (I-131) Capsules Company Product Type and Application
- 3.8 Global Kits and Iodine-131 (I-131) Capsules Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Kits and Iodine-131 (I-131) Capsules Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Kits and Iodine-131 (I-131) Capsules Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Kits and Iodine-131 (I-131) Capsules Market by Type
- 4.1 Kits and Iodine-131 (I-131) Capsules Type Introduction
- 4.1.1 Kits
- 4.1.2 Capsules
- 4.2 Global Kits and Iodine-131 (I-131) Capsules Sales Volume by Type
- 4.2.1 Global Kits and Iodine-131 (I-131) Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Kits and Iodine-131 (I-131) Capsules Sales Volume by Type (2021-2032)
- 4.2.3 Global Kits and Iodine-131 (I-131) Capsules Sales Volume Share by Type (2021-2032)
- 4.3 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Type
- 4.3.1 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Type (2021-2032)
- 4.3.3 Global Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type (2021-2032)
5 Kits and Iodine-131 (I-131) Capsules Market by Application
- 5.1 Kits and Iodine-131 (I-131) Capsules Application Introduction
- 5.1.1 Medical
- 5.1.2 Industrial
- 5.2 Global Kits and Iodine-131 (I-131) Capsules Sales Volume by Application
- 5.2.1 Global Kits and Iodine-131 (I-131) Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Kits and Iodine-131 (I-131) Capsules Sales Volume by Application (2021-2032)
- 5.2.3 Global Kits and Iodine-131 (I-131) Capsules Sales Volume Share by Application (2021-2032)
- 5.3 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Application
- 5.3.1 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Application (2021-2032)
- 5.3.3 Global Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application (2021-2032)
6 Kits and Iodine-131 (I-131) Capsules Regional Sales and Value Analysis
- 6.1 Global Kits and Iodine-131 (I-131) Capsules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Kits and Iodine-131 (I-131) Capsules Sales by Region (2021-2032)
- 6.2.1 Global Kits and Iodine-131 (I-131) Capsules Sales by Region: 2021-2026
- 6.2.2 Global Kits and Iodine-131 (I-131) Capsules Sales by Region (2027-2032)
- 6.3 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Region (2021-2032)
- 6.4.1 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Region: 2021-2026
- 6.4.2 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Region (2027-2032)
- 6.5 Global Kits and Iodine-131 (I-131) Capsules Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Kits and Iodine-131 (I-131) Capsules Sales Value (2021-2032)
- 6.6.2 North America Kits and Iodine-131 (I-131) Capsules Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Kits and Iodine-131 (I-131) Capsules Sales Value (2021-2032)
- 6.7.2 Europe Kits and Iodine-131 (I-131) Capsules Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Kits and Iodine-131 (I-131) Capsules Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Kits and Iodine-131 (I-131) Capsules Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Kits and Iodine-131 (I-131) Capsules Sales Value (2021-2032)
- 6.9.2 South America Kits and Iodine-131 (I-131) Capsules Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Kits and Iodine-131 (I-131) Capsules Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Kits and Iodine-131 (I-131) Capsules Sales Value Share by Country, 2025 VS 2032
7 Kits and Iodine-131 (I-131) Capsules Country-level Sales and Value Analysis
- 7.1 Global Kits and Iodine-131 (I-131) Capsules Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Kits and Iodine-131 (I-131) Capsules Sales by Country (2021-2032)
- 7.3.1 Global Kits and Iodine-131 (I-131) Capsules Sales by Country (2021-2026)
- 7.3.2 Global Kits and Iodine-131 (I-131) Capsules Sales by Country (2027-2032)
- 7.4 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Country (2021-2032)
- 7.4.1 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Country (2021-2026)
- 7.4.2 Global Kits and Iodine-131 (I-131) Capsules Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.9.2 France Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.16.2 China Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.19.2 India Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Kits and Iodine-131 (I-131) Capsules Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Kits and Iodine-131 (I-131) Capsules Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Kits and Iodine-131 (I-131) Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 NTP Radioisotopes SOC
- 8.1.1 NTP Radioisotopes SOC Company Information
- 8.1.2 NTP Radioisotopes SOC Business Overview
- 8.1.3 NTP Radioisotopes SOC Kits and Iodine-131 (I-131) Capsules Sales, Value and Gross Margin (2021-2026)
- 8.1.4 NTP Radioisotopes SOC Kits and Iodine-131 (I-131) Capsules Product Portfolio
- 8.1.5 NTP Radioisotopes SOC Recent Developments
- 8.2 Jubilant DraxImage
- 8.2.1 Jubilant DraxImage Company Information
- 8.2.2 Jubilant DraxImage Business Overview
- 8.2.3 Jubilant DraxImage Kits and Iodine-131 (I-131) Capsules Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Jubilant DraxImage Kits and Iodine-131 (I-131) Capsules Product Portfolio
- 8.2.5 Jubilant DraxImage Recent Developments
- 8.3 IRE - IRE ELiT
- 8.3.1 IRE - IRE ELiT Company Information
- 8.3.2 IRE - IRE ELiT Business Overview
- 8.3.3 IRE - IRE ELiT Kits and Iodine-131 (I-131) Capsules Sales, Value and Gross Margin (2021-2026)
- 8.3.4 IRE - IRE ELiT Kits and Iodine-131 (I-131) Capsules Product Portfolio
- 8.3.5 IRE - IRE ELiT Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Kits and Iodine-131 (I-131) Capsules Value Chain Analysis
- 9.1.1 Kits and Iodine-131 (I-131) Capsules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Kits and Iodine-131 (I-131) Capsules Sales Mode & Process
- 9.2 Kits and Iodine-131 (I-131) Capsules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Kits and Iodine-131 (I-131) Capsules Distributors
- 9.2.3 Kits and Iodine-131 (I-131) Capsules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst